Vitamin D supplementation: A iatrogenic hypercalcemia concerning an HIV-infected patient with disseminated tuberculosis;Supplémentation en vitamine D : Une hypercalcémie iatrogène chez un patient infecté par le VIH et atteint de tuberculose disséminée

Presse Medicale

Volumn 41, Issue 12 PART1, 2012, Pages 1299-1301

  Lescoat, Alain ^a   Poinsignon, Yves ^a   Dos Santos, Anabèle ^a   Cano, Yves ^b   Floc'h, Françoise ^c   Jardel, Henry ^a  

^a Centre hospitalier Bretagne Atlantique (CHBA)   (France)

^b CHBA   (France)

^c LABORATOIRE CERBA   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D;

DIET THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCALCEMIA; IATROGENIC DISEASE; LETTER; MILIARY TUBERCULOSIS; VITAMIN SUPPLEMENTATION;

EID: 84870685982     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2012.05.028     Document Type: Letter

References (8)

1. Cazanave C., Dupon M., Lavignolle-Aurillac V., Barthe N., Lawson-Ayayi S., Mehsen N., et al. Reduced bone mineral density in HIV-infected patients: prevalence and associated factors. AIDS 2008, 22(3):395-402.
2. Young B., Dao C.N., Buchacz K., Baker R., Brooks J.T. Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006. Clin Infect Dis 2011, 52(8):1061-1068.
3. McComsey G.A., Kendall M.A., Tebas P., Swindells S., Hogg E., Alston-Smith B., et al. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV. AIDS 2007, 18:2473-2482.
4. Benhamou C.L., Souberbielle J.C., Cortet B., Fardellone P., Gauvain J., Thomas T., et al. La vitamine D chez l'adulte : recommandations du GRIO. Presse Med 2011, 40:673-682.
5. Cadranel J., Garabédian M., Milleron B., et al. Vitamin D metabolism by immune and inflammatory cells from patients with tuberculosis: correlation with clinical manifestations and calcium metabolism. Eur Respir J 1994, 7:1103-1110.
6. Cadranel J., Garabédian M., Milleron B., Guillozzo H., Akoun G., Hance A.J. 1,25-(OH)2D 3 receptors on alveolar lymphocytes and alveola macrophages recovered by lavage from normocalcemic patients with tuberculosis. J Clin Invest 1990, 85:1588-1593.
7. Garabédian M, Cadranel J. Le 1,25-dihydroxycholecalciferol. In: Baud L. Médiateurs, aspects moléculaires et physiopathologiques. édition pradel, 1992:115-127.
8. Cadranel J. La « vitamine D » médiateur endocrine et paracrine au cours des granulomatoses pulmonaires. Rev Mal Resp 1995, 12:119-126.